More on DMAC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-5.6% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

DiaMedica Therapeutics Inc. (NQ:DMAC)
Delayed: 5.85 +0.12 (2.09%)
Prev. Close $5.73  
Open$5.76 
52 Wk High$ 
52 Wk Low$ 
Day High$5.87 
Day Low$5.61 
P/E N/A  
EPS$ 
Volume226,741 


Jun 16, 2026 08:30 AM DIAMEDICA gets FDA feedback on DM199 preeclampsia nonclinical work
Jun 16, 2026 08:30 AM DiaMedica Receives FDA Feedback on DM199 Preeclampsia Nonclinical Program
Jun 3, 2026 05:28 PM Form 4 DiaMedica Therapeutics For: Jun 01 Filed by: Giuffre Randall Michael
Jun 3, 2026 05:28 PM Form 4 DiaMedica Therapeutics For: Jun 01 Filed by: Kuntz Richard
Jun 3, 2026 05:27 PM Form 4 DiaMedica Therapeutics For: Jun 01 Filed by: O'Connor Daniel J.
Jun 3, 2026 05:27 PM Form 4 DiaMedica Therapeutics For: Jun 01 Filed by: Lewis Tanya
Jun 3, 2026 05:26 PM Form 4 DiaMedica Therapeutics For: Jun 01 Filed by: Semba Charles Pauling
Jun 3, 2026 05:24 PM Form 4 DiaMedica Therapeutics For: Jun 01 Filed by: Parsons James T.
Jun 3, 2026 05:24 PM Form 4 DiaMedica Therapeutics For: Jun 01 Filed by: Pauls Dietrich John
Jun 3, 2026 05:23 PM Form 4 DiaMedica Therapeutics For: Jun 01 Filed by: Kellen Scott
View All Articles

Entities mentioned with DMAC

View All Entities